Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00991185 · ClinicalTrials.gov registry record
Cerebrospinal Fluid (CSF) Pharmacokinetics of Antimicrobials in Children
A clinical trial of Infections, sponsored by Duke University.
- Completed
- Registry status
- 8
- Enrollment target
- 1
- Study location
NCT00991185: Completed study of Infections, sponsored by Duke University.
NCT00991185 is a study of Infections that has completed, run by Duke University. The registered enrollment target is 8 participants, below the 3,407-participant average among 26 other Infections trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00991185, a study of Infections, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn more about antimicrobials, especially drug levels in the CSF that would normally be used in young children as part of standard care. These drugs are approved by the Food and Drug Administration (FDA) for treating infections. They are used extensively in children in the United States, but they have not been extensively studied in children or babies. The investigators do not have very much information on how children and babies handle these drugs; that is, how long it takes for the drugs to be removed from the blood circulation and to pass out of the body and how much goes into the central nervous system. The investigators also do not have good information to guide how often the investigators should give the drugs to children and babies to get the maximum effect on infections with the minimum amount of drug. Thus, the investigators will collect more information about how these drugs should be used in children and babies by doing this drug levels research study.
Primary Outcome
CSF:serum ration of vancomycin
Conditions Studied
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2009-07 |
| Est. Completion | 2014-04 |
What the finished NCT00991185 record still lists
NCT00991185 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 3,407-participant average among 26 other Infections trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00991185 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00991185 about?
NCT00991185 is a clinical study titled "Cerebrospinal Fluid (CSF) Pharmacokinetics of Antimicrobials in Children". The purpose of this study is to learn more about antimicrobials, especially drug levels in the CSF that would normally be used in young children as part of standard care. These drugs are approved by the Food and Drug Administration (FDA) for treating infections. They are used extensively in children...
What is the current status of trial NCT00991185?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2009-07. Estimated completion is 2014-04.
What conditions does trial NCT00991185 study?
This clinical trial studies the following conditions: Infections.
Who is sponsoring clinical trial NCT00991185?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00991185 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00991185's enrollment target sits among peer trials
8 27th of 26 the lowest of 26 other Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
RECRUITING · Phase 1
-
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
RECRUITING · NA
-
Remote Sputum Collection in Cystic Fibrosis
RECRUITING
-
Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
RECRUITING
-
Augmented Reality For MRI-Guided Interventions
RECRUITING · NA
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia